Results 31 to 40 of about 41,883 (252)
Journal of Interventional Cardiology, 2022 Transcatheter aortic valve replacement (TAVR) to treat degeneration of bioprosthetic heart valves (BHVs), called as valve-in-valve (ViV), is becoming a key feature since the number of BHVs requiring intervention is increasing and many patients are at ...
Rodrigo Petersen Saadi +4 more
doaj +1 more source
Bioprosthetic Aortic Valve Degeneration: a Review from a Basic Science Perspective
Brazilian Journal of Cardiovascular Surgery, 2021 Introduction: The increase in the prevalence of aortic stenosis due to an aging population has led to an increasing number of surgical aortic valve replacements.
Tiago R Velho +5 more
doaj +1 more source
Patient Prosthesis Mismatch After SAVR and TAVR
Frontiers in Cardiovascular Medicine, 2022 Patient-prosthesis mismatch (PPM) remains one out of many factors to be considered during decision-making for the treatment of aortic valve pathologies. The idea of adequate sizing of a prosthetic heart valve was established by Rahimtoola already in 1978.
Sabine Bleiziffer, Tanja K. Rudolph
doaj +1 more source
Management of patients with transcatheter implantable aortic valve
Klinicist, 2023 Valvular heart disease remains one of the causes of cardiovascular morbidity and mortality worldwide. Aortic stenosis is the most common valvular pathology requiring cardiac surgery.
E. B. Luneva, E. G. Malev
doaj +1 more source
Frontiers in Cardiovascular Medicine, 2022 BackgroundInfective endocarditis is a complication with high mortality in patients with congenital heart disease, particularly for those with bioprosthetic valve.Case summaryWe report a case of a 54-year-old female with a history of tetralogy of Fallot ...
Yan-Jie Li, Xin Pan, Cheng Wang, Ben He
doaj +1 more source
Warfarin treatment quality and prognosis in patients with mechanical heart valve prosthesis
Heart, 2016 Objectives To study the impact of time in therapeutic range (TTR) and international normalised ratio (INR) variability on the risk of thromboembolic events, major bleeding complications and death after mechanical heart valve (MHV) implantation ...
B. Grzymala-Lubanski +4 more
semanticscholar +1 more source
Heart valve mechanical prosthesis: The perfect match until it is not - A case report.
Experimental and Therapeutic Medicine, 2020 Primary immune thrombocytopenia (ITP), formerly known as idiopathic thrombocytopenia, is defined by a reduced platelet count
I. Movileanu +3 more
semanticscholar +1 more source
European Heart Journal: Case Reports, 2021 Background Left ventricular non-compaction cardiomyopathy (LVNC) has been reported in association with almost all types of congenital heart valve disease.
A. Unbehaun +3 more
semanticscholar +1 more source
Advancements in left ventricular assist devices to prevent pump thrombosis and blood coagulopathy
Journal of Anatomy, Volume 242, Issue 1, Page 29-49, January 2023., 2023 Left ventricular assist device (LVAD)‐related blood coagulopathy: Pump thrombosis is one of the most severe adverse events caused by LVADs. The contact of blood with artificial materials of LVAD pumps and cannulas triggers the coagulation cascade. Abstract Mechanical circulatory support (MCS) devices, such as left ventricular assist devices (LVADs) are
Grainne Malone +12 more
wiley +1 more source